# Adaptimmune Therapeutics PLC: Form 8-K, filed Feb 16, 2024

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2024-02-16
- Accepted by EDGAR: Feb 16, 2024, 16:05 ET
- Period: 2024-02-16
- Accession: 0001558370-24-001304
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000155837024001304/adap-20240216x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000155837024001304/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000155837024001304/adap-20240216x8k.htm

Filed Feb 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-001304. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.